Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
9.07
-1.68 (-15.63%)
At close: Apr 28, 2026, 4:00 PM EDT
8.90
-0.17 (-1.88%)
Pre-market: Apr 29, 2026, 7:01 AM EDT
Artiva Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 224 | 105 | 245 | - | - | - | |
| Market Cap Growth | 364.73% | -56.99% | - | - | - | - | |
| Enterprise Value | 127 | -6 | 113 | - | - | - | |
| Last Close Price | 9.07 | 4.29 | 10.08 | - | - | - | |
| PS Ratio | - | - | 975.44 | - | - | - | |
| PB Ratio | 2.00 | 0.96 | 1.31 | - | - | - | |
| P/TBV Ratio | 2.04 | 0.96 | 1.31 | - | - | - | |
| EV/Sales Ratio | - | - | 450.89 | - | - | - | |
| Debt / Equity Ratio | 0.10 | 0.10 | 0.08 | 0.31 | 0.26 | 0.01 | |
| Net Debt / Equity Ratio | -0.88 | -0.88 | -0.92 | -1.10 | -1.10 | -1.25 | |
| Net Debt / EBITDA Ratio | 1.11 | 1.11 | 2.64 | 2.11 | 1.42 | 3.00 | |
| Net Debt / FCF Ratio | 1.22 | 1.22 | 3.07 | 1.19 | 1.45 | 9.35 | |
| Asset Turnover | - | - | 0.00 | 0.28 | 0.03 | 0.02 | |
| Quick Ratio | 8.31 | 8.31 | 15.22 | 6.45 | 4.02 | 8.36 | |
| Current Ratio | 8.61 | 8.61 | 15.40 | 6.53 | 4.09 | 8.41 | |
| Return on Equity (ROE) | -56.55% | -56.55% | -54.24% | -44.15% | -57.84% | -99.72% | |
| Return on Assets (ROA) | -32.97% | -32.97% | -26.72% | -16.10% | -24.68% | -33.43% | |
| Return on Capital Employed (ROCE) | -76.20% | -76.20% | -34.10% | -33.00% | -55.70% | -35.40% | |
| Earnings Yield | -37.41% | -79.65% | -26.70% | - | - | - | |
| FCF Yield | -35.39% | -75.35% | -22.74% | - | - | - | |
| Buyback Yield / Dilution | -117.11% | -117.11% | -1302.54% | -4.70% | -11.80% | -8.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.